Overview

Relapse Prevention Study in Newly Abstinent Smokers

Status:
Withdrawn
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of GSK598809 as compared to placebo in preventing recently-quit smokers from going back to smoking.
Phase:
Phase 2
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Nicotine